Iman Tavassoly currently serves as the Associate Director of Quantitative and Systems Pharmacology at Alnylam Pharmaceuticals, a position held since June 2025. Prior to this, Iman co-founded QMed Insights and VegBoom in 2025 and served as the Director of Quantitative Pharmacology at Repare Therapeutics from August 2023 to September 2024, focusing on innovation in oncology through Quantitative Pharmacology and AI-based modeling. Iman also held senior leadership roles at C2i Genomics, contributing to R&D and Clinical Development in Precision Oncology from September 2020 to August 2023, including a tenure as Scientific Director. Iman holds a PhD in Genetics, Bioinformatics, and Computational Biology from Virginia Tech and completed a Leadership Principles certificate program at Harvard Business School Online in 2021.
This person is not in any teams
This person is not in any offices